+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Flow-cytometric and quantitative histologic parameters as prognostic indicators for occult retroperitoneal disease in clinical-stage-I non-seminomatous testicular germ-cell tumors



Flow-cytometric and quantitative histologic parameters as prognostic indicators for occult retroperitoneal disease in clinical-stage-I non-seminomatous testicular germ-cell tumors



International Journal Of Cancer. 57(5): 628-633



Our study was performed to clarify whether the combination of DNA flow-cytometric and quantitative histopathological parameters improves the prediction of occult metastatic disease in clinical stage-I non-seminomatous testicular germ-cell tumors (NSGCT). We used archival paraffin primary-tumor tissue of 67 clinical stage-I NSGCT patients who had undergone retroperitoneal lymph-node dissection (RPLND). According to the RPLND specimens, 24 patients were at pathological stage I and 43 at pathological stage II. Archival blocks were redissected for histological re-evaluation. In addition, 50 microns sections were prepared according to the Hedley technique in order to obtain nuclear suspensions which were processed for flow cytometry (FC). In univariate analysis, the percentage of embryonal carcinoma, the percentage of immature teratoma and vascular invasion were the most accurate predictive histopathological parameters. The percentage of aneuploid cells in S-phase was the best predictive FC parameter. In multivariate analysis, the percentage of embryonal carcinoma and the S-phase fraction of aneuploid cells were the only independent markers for occult metastatic disease. According to this statistical approach, 91.0% of pathological stage-I and stage-II cases were correctly classified. Sensitivity was 95.3% and specificity was 83.3%. Using histopathological criteria alone, only 56.7% NSGCT patients were correctly classified.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008693145

Download citation: RISBibTeXText

PMID: 8194868

DOI: 10.1002/ijc.2910570503


Related references

Flow cytometric and quantitative histological parameters to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors. Journal of Urology 150(3): 879-883, 1993

Flow cytometric proliferative activity to predict occult disease in clinical stage i nonseminomatous testicular germ cell tumors. Proceedings of the American Association for Cancer Research Annual Meeting 33: 207, 1992

Flow cytometric dna ploidy pattern for predicting metastases of clinical stage i non seminomatous germ cell testicular tumors. Journal of Urology 143(4 Suppl.): 395A, 1990

DNA cytometric and histologic parameters as prognosticators in clinical stage I nonseminomatous testicular germ cell tumors. Journal of Cancer Research & Clinical Oncology 120(Suppl. ): R56, 1994

Concordance and prediction ability of original and reviewed vascular invasion and other prognostic parameters of clinical stage I nonseminomatous germ cell testicular tumors after retroperitoneal lymph node dissection. Journal of Urology 186(4): 1298-1302, 2011

Prediction of occult metastases in patients with clinical stage I non-seminomatous germ cell tumors First results of the prospective multicenter trial of the German Testicular Cancer Study Group. Journal of Urology 165(5 Suppl.): 152, 2001

Reduced retroperitoneal lymphadenectomy for clinical stage I non seminomatous germ cell testicular cancer. Archivos Espanoles de Urologia 60(3): 245-254, 2007

Prognostic indicators for failure of surveillance management of stage i non seminomatous germ cell tumors. Australian & New Zealand Journal of Surgery 59(2): 119-122, 1989

New prognostic parameters to predict pathological stage in clinical stage A nonseminomatous testicular germ cell tumors. Journal of Urology 153(4 Suppl. ): 244A, 1995

Low sperm counts as a prognostic factor of progression in stage i non seminomatous germ cell testicular tumors. British Journal of Urology 62(1): 82-84, 1988

Flow cytometric DNA ploidy pattern for predicting metastasis of clinical stage I nonseminomatous germ cell testicular tumors. Urology 41(4): 379-383, 1993

Laparoscopic retroperitoneal lymphnode dissection (L-RPLND) for clinical stage I non seminomatous germ cell testicular tumour (NSGCTT). 2007

Is modified retroperitoneal lymph node dissection alive for clinical stage I non-seminomatous germ cell testicular tumor?. Urology Journal 10(2): 873-877, 2013